Clinical trials
Completed Spondylarthritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 8 |
| 2014 | 3 |
| 2015 | 8 |
| 2016 | 9 |
| 2017 | 9 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 96 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 6 |
| Centre Hospitalier Universitaire de Nice | 4 |
| Diakonhjemmet Hospital | 4 |
| Eli Lilly and Company | 4 |
| University Hospital, Grenoble | 4 |
| AbbVie | 3 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 3 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| University Hospital, Clermont-Ferrand | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spondylarthritis | 96 |
| Spondylitis, Ankylosing | 30 |
| Arthritis, Rheumatoid | 26 |
| Arthritis, Psoriatic | 20 |
| Spondylarthropathies | 16 |
| Arthritis | 6 |
| Crohn Disease | 6 |
| Axial Spondyloarthritis | 4 |
| Colitis, Ulcerative | 4 |
| Spondylitis | 4 |
Trials
Showing 26 to 50 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.